Free Trial

Eaton Vance Senior Floating-Rate Trust (EFR) Short Interest Ratio & Short Volume

Eaton Vance Senior Floating-Rate Trust logo
$12.73
-0.01 (-0.08%)
(As of 11:02 AM ET)

Eaton Vance Senior Floating-Rate Trust Short Interest Data

Eaton Vance Senior Floating-Rate Trust (EFR) has a short interest of 110,200 shares. This marks a -8.77% decrease in short interest from the previous month. The short interest ratio (days to cover) is 1.2, indicating that it would take 1.2 days of the average trading volume of 90,001 shares to cover all short positions.

Current Short Interest
110,200 shares
Previous Short Interest
120,800 shares
Change Vs. Previous Month
-8.77%
Dollar Volume Sold Short
$1.40 million
Short Interest Ratio
1.2 Days to Cover
Last Record Date
October 15, 2024
Today's Trading Volume
26,192 shares
Average Trading Volume
90,001 shares
Today's Volume Vs. Average
29%
Short Selling Eaton Vance Senior Floating-Rate Trust?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Eaton Vance Senior Floating-Rate Trust and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

EFR Short Interest Over Time

EFR Days to Cover Over Time

EFR Percentage of Float Shorted Over Time

Eaton Vance Senior Floating-Rate Trust Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
10/15/2024110,200 shares $1.40 million -8.8%N/A1.2 $12.68
9/30/2024120,800 shares $1.53 million -6.5%N/A1.4 $12.68
9/15/2024129,200 shares $1.65 million -1.2%N/A1.5 $12.77
8/31/2024130,700 shares $1.67 million -29.3%N/A1.5 $12.77
8/15/2024184,800 shares $2.37 million -12.2%N/A2.1 $12.81
7/31/2024210,500 shares $2.77 million +2.6%N/A2.2 $13.15
7/15/2024205,200 shares $2.70 million +1.0%N/A2.2 $13.14
6/30/2024203,200 shares $2.66 million +40.0%N/A2.1 $13.08
6/15/2024145,100 shares $1.89 million -14.0%N/A1.5 $13.01
5/31/2024168,800 shares $2.22 million +40.7%N/A1.7 $13.14
5/15/2024120,000 shares $1.59 million -2.8%N/A1.2 $13.24
4/30/2024123,500 shares $1.62 million +23.8%N/A1.3 $13.08
4/15/202499,800 shares $1.30 million +23.4%N/A1.1 $13.00
3/31/202480,900 shares $1.05 million +51.8%N/A0.9 $13.03
3/15/202453,300 shares $691,301.00 -40.7%N/A0.6 $12.97
2/29/202489,800 shares $1.17 million +12.0%N/A1 $12.98
2/15/202480,200 shares $1.05 million -44.3%N/A0.9 $13.13
1/31/2024144,000 shares $1.90 million -8.2%N/A1.5 $13.18
1/15/2024156,800 shares $1.99 million +30.9%N/A1.6 $12.69
12/31/2023119,800 shares $1.52 million +23.3%N/A1.2 $12.66
12/15/202397,200 shares $1.24 million +39.9%N/A1 $12.76
11/30/202369,500 shares $856,240.00 -10.9%N/A0.8 $12.32
11/15/202378,000 shares $956,280.00 +561.0%N/A0.9 $12.26
10/31/202311,800 shares $137,352.00 -77.0%N/A0.2 $11.64
10/15/202351,400 shares $625,024.00 +38.9%N/A0.7 $12.16
9/30/202337,000 shares $448,070.00 +33.1%N/A0.5 $12.11
9/15/202327,800 shares $335,824.00 -52.6%N/A0.4 $12.08
8/31/202358,700 shares $706,161.00 -17.6%N/A0.9 $12.03
8/15/202371,200 shares $865,080.00 -25.2%N/A1 $12.15
7/31/202395,200 shares $1.16 million +7.5%N/A1.4 $12.17
7/15/202388,600 shares $1.05 million +0.6%N/A1.3 $11.81
6/30/202388,100 shares $1.04 million +105.8%N/A1.4 $11.75
6/15/202342,800 shares $490,488.00 +125.3%N/A0.7 $11.46
5/31/202319,000 shares $212,040.00 -7.8%N/A0.3 $11.16
5/15/202320,600 shares $231,956.00 +15.1%N/A0.3 $11.26
4/30/202317,900 shares $206,460.39 -39.3%N/A0.3 $11.53
4/15/202329,500 shares $337,775.00 -33.3%N/A0.4 $11.45
3/31/202344,200 shares $500,786.00 -28.8%N/A0.6 $11.33
3/15/202362,100 shares $707,319.00 -5.2%N/A0.8 $11.39
2/28/202365,500 shares $782,070.00 +149.1%N/A0.7 $11.94
NASDAQ traded stock with a BIG short position. (Ad)

Small cap NASDAQ firm is an innovative leader in non-opioid pain therapeutics. The company’s offerings could significantly aid in stopping the opioid crisis and create maximum shareholder growth!

See how this NASDAQ Bio-tech is offering viable solutions
2/15/202326,300 shares $317,967.00 -35.5%N/A0.3 $12.09
1/31/202340,800 shares $480,624.00 +142.9%N/A0.4 $11.78
1/15/202316,800 shares $193,536.00 +24.4%N/A0.2 $11.52
12/30/202213,500 shares $147,690.00 +107.7%N/A0.1 $10.94
12/15/20226,500 shares $72,215.00 -77.5%N/A0.1 $11.11
11/30/202228,900 shares $335,240.00 +61.5%N/A0.3 $11.60
11/15/202217,900 shares $203,702.00 -15.2%N/A0.2 $11.38
10/31/202221,100 shares $235,687.00 -5.4%N/A0.2 $11.17
10/15/202222,300 shares $240,394.00 No ChangeN/A0.2 $10.78
9/30/202226,600 shares $295,526.00 +329.0%N/A0.3 $11.11
9/15/20226,200 shares $71,176.00 +10.7%N/A0.1 $11.48
8/31/20225,600 shares $67,032.00 -88.6%N/A0.1 $11.97
8/15/202249,100 shares $638,791.00 -34.7%N/A0.6 $13.01
7/31/202275,200 shares $944,512.00 -48.1%N/A0.7 $12.56
7/15/2022144,900 shares $1.73 million +3.8%N/A1.2 $11.97
6/30/2022139,600 shares $1.71 million -21.0%N/A1.1 $12.27
6/15/2022176,700 shares $2.18 million +265.1%N/A1.3 $12.32
5/31/202248,400 shares $586,608.00 +328.3%N/A0.4 $12.12
5/15/202211,300 shares $132,436.00 -56.0%N/A0.1 $11.72
4/30/202225,700 shares $332,044.00 -17.4%N/A0.2 $12.92
4/15/202231,100 shares $420,161.00 -50.7%N/A0.3 $13.51
3/31/202263,100 shares $846,171.00 -10.1%N/A0.4 $13.41
3/15/202270,200 shares $906,282.00 -32.6%N/A0.5 $12.91
2/28/2022104,100 shares $1.46 million +10.4%N/A0.8 $14.05
2/15/202294,300 shares $1.37 million +212.3%N/A0.7 $14.50
1/31/202230,200 shares $432,162.00 -90.5%N/A0.2 $14.31
1/15/2022317,700 shares $4.59 million +42.9%N/A2.3 $14.46
12/31/2021222,300 shares $3.28 million -0.7%N/A2.2 $14.76
12/15/2021223,900 shares $3.31 million -8.5%N/A2.2 $14.78
11/30/2021244,800 shares $3.64 million -27.6%N/A2.4 $14.85
11/15/2021338,300 shares $5.21 million +21.7%N/A3.4 $15.39
10/29/2021278,000 shares $4.14 million -28.2%N/A2.9 $14.90
10/15/2021387,300 shares $5.89 million +20.8%N/A3.8 $15.22
9/30/2021320,500 shares $4.68 million +42.6%N/A2.6 $14.61
9/15/2021224,800 shares $3.23 million +11.0%N/A1.9 $14.39
8/31/2021202,600 shares $2.91 million -0.1%N/A1.7 $14.34
8/13/2021202,700 shares $2.92 million +2.8%N/A1.6 $14.43
7/30/2021197,200 shares $2.75 million +1,416.9%N/A1.4 $13.96
7/15/202113,000 shares $184,080.00 -28.2%N/A0.1 $14.16
6/30/202118,100 shares $256,115.00 -49.7%N/A0.2 $14.15
6/15/202136,000 shares $513,000.00 -34.3%N/A0.3 $14.25
5/28/202154,800 shares $777,612.00 +34.0%N/A0.5 $14.19
5/14/202140,900 shares $572,395.50 -51.9%N/A0.3 $14.00
4/30/202185,000 shares $1.18 million +68.3%N/A0.7 $13.88
4/15/202150,500 shares $710,030.00 -42.6%N/A0.4 $14.06
3/31/202187,900 shares $1.22 million +12.3%N/A0.7 $13.85
3/15/202178,300 shares $1.07 million +903.9%N/A0.5 $13.61
2/26/20217,800 shares $103,896.00 -53.9%N/A0.1 $13.32
2/12/202116,900 shares $230,009.00 +12.7%N/A0.1 $13.61
1/29/202115,000 shares $198,600.00 -31.5%N/A0.1 $13.24
NASDAQ traded stock with a BIG short position. (Ad)

Small cap NASDAQ firm is an innovative leader in non-opioid pain therapeutics. The company’s offerings could significantly aid in stopping the opioid crisis and create maximum shareholder growth!

See how this NASDAQ Bio-tech is offering viable solutions
1/15/202121,900 shares $293,898.00 -94.2%N/A0.2 $13.42
12/31/2020380,300 shares $4.87 million +448.0%N/A3.1 $12.80
12/15/202069,400 shares $887,626.00 +159.0%N/A0.7 $12.79
11/30/202026,800 shares $341,700.00 +92.8%N/A0.3 $12.75
11/15/202013,900 shares $176,669.00 -80.1%N/A0.2 $12.71
10/30/202069,900 shares $831,111.00 -35.5%N/A0.8 $11.89
10/15/2020108,400 shares $1.35 million +1,870.9%N/A0 $12.42
9/30/20205,500 shares $63,965.00 -80.4%N/A0.1 $11.63
9/15/20206,900 shares $83,214.00 -75.4%N/A0.1 $12.06
8/31/202028,000 shares $332,640.00 -70.1%N/A0.3 $11.88
8/14/202093,600 shares $1.10 million +70.5%N/A1 $11.79
7/31/202054,900 shares $633,546.00 +57.3%N/A0.6 $11.54
7/15/202034,900 shares $394,370.00 -14.0%N/A0.3 $11.30
6/30/202040,600 shares $452,690.00 -64.4%N/A0.3 $11.15
6/15/2020114,000 shares $1.32 million +20.6%N/A0.6 $11.59
5/29/202094,500 shares $1.05 million +132.2%N/A0.3 $11.12
5/15/202040,700 shares $423,687.00 -10.9%N/A0.1 $10.41
4/30/202045,700 shares $482,135.00 -44.2%N/A0.1 $10.55
4/15/202081,900 shares $862,407.00 -48.1%N/A0.3 $10.53
3/31/2020157,800 shares $1.67 million +9.0%N/A0.5 $10.56
3/13/2020144,800 shares $1.56 million +139.3%0.4%0.7 $10.75
2/28/202060,500 shares $478,555.00 -19.3%N/A0.3 $7.91
2/14/202075,000 shares $896,250.00 -35.8%N/A0.4 $11.95
1/31/2020116,800 shares $1.55 million -65.9%N/A0.6 $13.30
1/15/2020342,600 shares $4.66 million +281.1%N/A1.8 $13.60
12/31/201989,900 shares $1.24 million +222.2%N/A0.5 $13.79

EFR Short Interest - Frequently Asked Questions

What is Eaton Vance Senior Floating-Rate Trust's current short interest?

Short interest is the volume of Eaton Vance Senior Floating-Rate Trust shares that have been sold short but have not yet been closed out or covered. As of October 15th, investors have sold 110,200 shares of EFR short. Learn More on Eaton Vance Senior Floating-Rate Trust's current short interest.

What is a good short interest ratio for Eaton Vance Senior Floating-Rate Trust?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. EFR shares currently have a short interest ratio of 1.0. Learn More on Eaton Vance Senior Floating-Rate Trust's short interest ratio.

Is Eaton Vance Senior Floating-Rate Trust's short interest increasing or decreasing?

Eaton Vance Senior Floating-Rate Trust saw a decline in short interest in October. As of October 15th, there was short interest totaling 110,200 shares, a decline of 8.8% from the previous total of 120,800 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.14 billion), AppLovin Co. ($3.15 billion), Paychex, Inc. ($2.69 billion), Nu Holdings Ltd. ($2.48 billion), Cencora, Inc. ($2.24 billion), International Paper ($2.04 billion), Tractor Supply ($1.96 billion), Coinbase Global, Inc. ($1.93 billion), Moderna, Inc. ($1.91 billion), and SoFi Technologies, Inc. ($1.84 billion). View all of the most shorted stocks.

What does it mean to sell short Eaton Vance Senior Floating-Rate Trust stock?

Short selling EFR is an investing strategy that aims to generate trading profit from Eaton Vance Senior Floating-Rate Trust as its price is falling. EFR shares are trading down $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Eaton Vance Senior Floating-Rate Trust?

A short squeeze for Eaton Vance Senior Floating-Rate Trust occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of EFR, which in turn drives the price of the stock up even further.

How often is Eaton Vance Senior Floating-Rate Trust's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including EFR, twice per month. The most recent reporting period available is October, 15 2024.




This page (NYSE:EFR) was last updated on 11/5/2024 by MarketBeat.com Staff
From Our Partners